Skip to main content
Skip to navigation

All MpoxVax AFRIVAC articles

News
New international research alliance to tackle Mpox epidemic in Africa

2024-10-21T08:23:00Z

MpoxVax AFRIVAC is a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.